Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 261

Similar articles for PubMed (Select 16239577)

2.

Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.

Kolibab K, Yang A, Derrick SC, Waldmann TA, Perera LP, Morris SL.

Clin Vaccine Immunol. 2010 May;17(5):793-801. doi: 10.1128/CVI.00006-10. Epub 2010 Mar 31.

3.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
4.
5.

Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.

Triccas JA, Shklovskaya E, Spratt J, Ryan AA, Palendira U, Fazekas de St Groth B, Britton WJ.

Infect Immun. 2007 Nov;75(11):5368-75. Epub 2007 Aug 27.

6.

Immune responses and protective efficacy of the gene vaccine expressing Ag85B and ESAT6 fusion protein from Mycobacterium tuberculosis.

Chang-hong S, Xiao-wu W, Hai Z, Ting-fen Z, Li-Mei W, Zhi-kai X.

DNA Cell Biol. 2008 Apr;27(4):199-207. doi: 10.1089/dna.2007.0648.

PMID:
18163878
8.

A DNA vaccine expressing CFP21 and MPT64 fusion protein enhances BCG-induced protective immunity against Mycobacterium tuberculosis infection in mice.

Wang C, Chen Z, Fu R, Zhang Y, Chen L, Huang L, Li J, Shi C, Fan X.

Med Microbiol Immunol. 2011 Aug;200(3):165-75. doi: 10.1007/s00430-011-0188-z. Epub 2011 Feb 22.

PMID:
21340709
9.

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.

Yuan W, Dong N, Zhang L, Liu J, Lin S, Xiang Z, Qiao H, Tong W, Qin C.

Vaccine. 2012 Mar 23;30(14):2490-7. doi: 10.1016/j.vaccine.2011.06.029. Epub 2011 Jun 23.

PMID:
21704108
10.
12.

An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.

Wang QL, Pan Q, Ma Y, Wang K, Sun P, Liu S, Zhang XL.

Vaccine. 2009 Nov 12;27(48):6712-22. doi: 10.1016/j.vaccine.2009.08.096. Epub 2009 Sep 4.

PMID:
19733584
13.

Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses.

Goter-Robinson C, Derrick SC, Yang AL, Jeon BY, Morris SL.

Vaccine. 2006 Apr 24;24(17):3522-9. Epub 2006 Feb 20.

PMID:
16519971
14.

The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.

Palma C, Iona E, Giannoni F, Pardini M, Brunori L, Orefici G, Fattorini L, Cassone A.

Cell Microbiol. 2007 Jun;9(6):1455-65. Epub 2007 Jan 22.

PMID:
17250590
15.

[A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis].

Luo XD, Zhu DY, Chen Q, Jiang Y, Jiang S, Yang C.

Zhonghua Jie He He Hu Xi Za Zhi. 2004 Sep;27(9):611-6. Chinese.

PMID:
15498274
17.

Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis.

Kamath AT, Feng CG, Macdonald M, Briscoe H, Britton WJ.

Infect Immun. 1999 Apr;67(4):1702-7.

18.

Prime-boost BCG vaccination with DNA vaccines based in β-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model.

Cervantes-Villagrana AR, Hernández-Pando R, Biragyn A, Castañeda-Delgado J, Bodogai M, Martínez-Fierro M, Sada E, Trujillo V, Enciso-Moreno A, Rivas-Santiago B.

Vaccine. 2013 Jan 11;31(4):676-84. doi: 10.1016/j.vaccine.2012.11.042. Epub 2012 Nov 26.

PMID:
23196205
19.

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.

Wang J, Thorson L, Stokes RW, Santosuosso M, Huygen K, Zganiacz A, Hitt M, Xing Z.

J Immunol. 2004 Nov 15;173(10):6357-65.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk